Clinical trials
Observational Venous Thromboembolism trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 9 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Assiut University | 1 |
| Beijing Friendship Hospital | 1 |
| Capital Medical University | 1 |
| Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 1 |
| Cork University Maternity Hospital | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Venous Thromboembolism | 48 |
| Pulmonary Embolism | 11 |
| Venous Thrombosis | 8 |
| Neoplasms | 6 |
| Thromboembolism | 5 |
| Atrial Fibrillation | 4 |
| Thrombosis | 4 |
| Thrombophilia | 3 |
| Colorectal Neoplasms | 2 |
| Hemorrhage | 2 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.